ATE431835T1 - Verfahren zum schutz von thiolgruppen in antikörpern - Google Patents

Verfahren zum schutz von thiolgruppen in antikörpern

Info

Publication number
ATE431835T1
ATE431835T1 AT03780938T AT03780938T ATE431835T1 AT E431835 T1 ATE431835 T1 AT E431835T1 AT 03780938 T AT03780938 T AT 03780938T AT 03780938 T AT03780938 T AT 03780938T AT E431835 T1 ATE431835 T1 AT E431835T1
Authority
AT
Austria
Prior art keywords
antibodies
thiol groups
protecting thiol
protecting
protein
Prior art date
Application number
AT03780938T
Other languages
English (en)
Inventor
Kenji Sasaki
Yasuhiko Katsumura
Original Assignee
Mitsubishi Tanabe Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Tanabe Pharma Corp filed Critical Mitsubishi Tanabe Pharma Corp
Application granted granted Critical
Publication of ATE431835T1 publication Critical patent/ATE431835T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
    • C07K1/061General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups
    • C07K1/066General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups for omega-amido functions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/006General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length of peptides containing derivatised side chain amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1077General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT03780938T 2002-12-20 2003-12-19 Verfahren zum schutz von thiolgruppen in antikörpern ATE431835T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002370822 2002-12-20
PCT/JP2003/016362 WO2004056872A1 (ja) 2002-12-20 2003-12-19 タンパク質のチオール基を保護する方法

Publications (1)

Publication Number Publication Date
ATE431835T1 true ATE431835T1 (de) 2009-06-15

Family

ID=32677181

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03780938T ATE431835T1 (de) 2002-12-20 2003-12-19 Verfahren zum schutz von thiolgruppen in antikörpern

Country Status (9)

Country Link
US (1) US20060257393A1 (de)
EP (1) EP1574521B1 (de)
JP (1) JPWO2004056872A1 (de)
AT (1) ATE431835T1 (de)
AU (1) AU2003289455A1 (de)
CA (1) CA2511228A1 (de)
DE (1) DE60327715D1 (de)
ES (1) ES2326076T3 (de)
WO (1) WO2004056872A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR103173A1 (es) 2014-12-22 2017-04-19 Novarits Ag Productos farmacéuticos y composiciones líquidas estables de anticuerpos il-17
AR103172A1 (es) 2014-12-22 2017-04-19 Novartis Ag Reducción selectiva de residuos de cisteina en anticuerpos il-17

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4734362A (en) * 1986-02-03 1988-03-29 Cambridge Bioscience Corporation Process for purifying recombinant proteins, and products thereof
DE3851685D1 (de) * 1987-10-13 1994-11-03 Thomae Gmbh Dr K Verfahren zur Herstellung von Proteinen.
US5130418A (en) * 1989-05-02 1992-07-14 California Biotechnology Inc. Method to stabilize basic fibroblast growth factor
CA2094378A1 (en) * 1990-10-25 1992-04-26 Paul B. Fisher Development of dna probes and immunological reagents of human tumor associated antigens
US5284830A (en) * 1991-02-13 1994-02-08 The Board Of Trustees Of The Leland Stanford Junior University Thyroid-derived chondrocyte-stimulating factor
JP3220180B2 (ja) * 1991-05-23 2001-10-22 三菱化学株式会社 薬剤含有タンパク質結合リポソーム
JP3236667B2 (ja) * 1991-06-28 2001-12-10 三菱化学株式会社 ヒト型モノクローナル抗体およびそれをコードする遺伝子、ハイブリドーマ並びに抗腫瘍剤
CA2072249C (en) * 1991-06-28 2003-06-17 Saiko Hosokawa Human monoclonal antibody specifically binding to surface antigen of cancer cell membrane
CA2137561C (en) * 1992-07-06 2001-10-23 Thomas R. Sykes Photoactivation of proteins for conjugation purposes
DE69636739T2 (de) * 1995-12-21 2007-10-18 Ajinomoto Co., Inc. Verfahren zur rückfaltung von menschlichem activin a
TR199802584T2 (xx) * 1996-06-11 1999-03-22 Boehringer Mannheim Gmbh Denat�re proteinin aktive edilmesi i�in y�ntem.
US20030120042A1 (en) * 2000-03-30 2003-06-26 Takao Yamada Process for producing recombinant protein
JP4249028B2 (ja) * 2001-12-04 2009-04-02 田辺三菱製薬株式会社 蛋白質の活性化方法

Also Published As

Publication number Publication date
ES2326076T3 (es) 2009-09-30
EP1574521A1 (de) 2005-09-14
CA2511228A1 (en) 2004-07-08
DE60327715D1 (de) 2009-07-02
US20060257393A1 (en) 2006-11-16
EP1574521A4 (de) 2006-04-12
AU2003289455A1 (en) 2004-07-14
WO2004056872A1 (ja) 2004-07-08
JPWO2004056872A1 (ja) 2006-04-20
EP1574521B1 (de) 2009-05-20

Similar Documents

Publication Publication Date Title
ATE392430T1 (de) Verfahren zur herstellung von dipeptiden
NO2020016I1 (no) efmoroktokog alfa - forlenget SPC
DE60308525D1 (de) Verfahren zur herstellung einer rasch erstarrten legierung für magnete
DE60336768D1 (de) Dichtpatrone für eine Raupenkette
DE60330541D1 (de) System zum Verfolgen von Poststücken
DE60335733D1 (de) Verfahren zur solubilisierung von protein
AU2003250825A8 (en) Inhibitors of glycoprotein vi
DE602004026912D1 (de) Formulierungen und verfahren zum denaturieren von proteinen
DE60336701D1 (de) Verfahren zum Ersetzen von Turbinenmantelträgerteilen
DE60028936D1 (de) Cyclosporin-derivate und verfahren zu deren herstellung
ATE348043T1 (de) Verfahren zum fördern von beuteln.
TW200518759A (en) Anti-infective agents
DK0967703T3 (da) Anordning af fastgörelseselementer til at holde bundter omspændt med kabelbindere
DE50303241D1 (de) Verfahren zur bereitstellung von abwesenheitsinformation
PE20040703A1 (es) Derivados aldehido de polietilenglicol
EA200600042A1 (ru) Способы образования дисульфидных связей и гликозилирования белков и реагенты, применяемые в этих способах
ATE431835T1 (de) Verfahren zum schutz von thiolgruppen in antikörpern
DE60316234D1 (de) Verfahren zum Schutz von Artikeln, und entsprechende Zusammensetzungen
DE60201984D1 (de) Werkzeugstahl von hoher zähigkeit, verfahren zum herstellen von teilen aus diesem stahl und so hergestellte teile
EP1533296A4 (de) Sulfenylverbindung, markierungsreagens und verfahren zur analyse von peptid
DK0914605T3 (da) Molekylemodel for VLA-4-inhibitorer
DE60333893D1 (de) Verfahren und System zum Etikettieren von Postsendungen
ATE356670T1 (de) Verfahren zur aufbereitung von sulfidmineralien
DE10344113A1 (de) Vorrichtung und Verfahren zum Verbinden von Wafern
DE50212060D1 (de) Vorrichtung zur Behandlung von Werkstücken

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties